Quoin Pharmaceuticals Future Growth
Future criteria checks 3/6
Quoin Pharmaceuticals is forecast to grow earnings and revenue by 60.1% and 70.5% per annum respectively while EPS is expected to grow by 71.8% per annum.
Key information
60.1%
Earnings growth rate
71.8%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | 70.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 10 | -7 | N/A | N/A | 3 |
| 12/31/2025 | N/A | -11 | N/A | N/A | 3 |
| 12/31/2024 | N/A | -9 | N/A | N/A | 3 |
| 9/30/2024 | N/A | -9 | -9 | -9 | N/A |
| 6/30/2024 | N/A | -8 | -8 | -8 | N/A |
| 3/31/2024 | N/A | -8 | -8 | -8 | N/A |
| 12/31/2023 | N/A | -9 | -8 | -8 | N/A |
| 9/30/2023 | N/A | -9 | -7 | -7 | N/A |
| 6/30/2023 | N/A | -10 | -8 | -8 | N/A |
| 3/31/2023 | N/A | -10 | -8 | -8 | N/A |
| 12/31/2022 | N/A | -9 | -8 | -8 | N/A |
| 9/30/2022 | N/A | -19 | -10 | -10 | N/A |
| 6/30/2022 | N/A | -18 | -8 | -8 | N/A |
| 3/31/2022 | N/A | -19 | -7 | -7 | N/A |
| 12/31/2021 | N/A | -21 | -6 | -6 | N/A |
| 9/30/2021 | N/A | -11 | -3 | -3 | N/A |
| 6/30/2021 | N/A | -10 | -2 | -2 | N/A |
| 3/31/2021 | N/A | -6 | -1 | -1 | N/A |
| 12/31/2020 | N/A | -2 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: QNRX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: QNRX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: QNRX is expected to become profitable in the next 3 years.
Revenue vs Market: QNRX is forecast to have no revenue next year.
High Growth Revenue: QNRX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if QNRX's Return on Equity is forecast to be high in 3 years time